These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial. Pini M; Pattachini C; Quintavalla R; Poli T; Megha A; Tagliaferri A; Manotti C; Dettori AG Thromb Haemost; 1990 Oct; 64(2):222-6. PubMed ID: 2270531 [TBL] [Abstract][Full Text] [Related]
3. [Drug therapy of deep venous thrombosis]. Bounameaux H Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349 [TBL] [Abstract][Full Text] [Related]
4. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. Hull RD; Raskob GE; Hirsh J; Jay RM; Leclerc JR; Geerts WH; Rosenbloom D; Sackett DL; Anderson C; Harrison L N Engl J Med; 1986 Oct; 315(18):1109-14. PubMed ID: 3531862 [TBL] [Abstract][Full Text] [Related]
5. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792 [TBL] [Abstract][Full Text] [Related]
7. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis. Wheeler AP; Jaquiss RD; Newman JH Arch Intern Med; 1988 Jun; 148(6):1321-5. PubMed ID: 3377615 [TBL] [Abstract][Full Text] [Related]
8. Use of the subcutaneous heparin pump during pregnancy. Barss VA; Schwartz PA; Greene MF; Phillippe M; Saltzman D; Frigoletto FD J Reprod Med; 1985 Dec; 30(12):899-901. PubMed ID: 4078826 [TBL] [Abstract][Full Text] [Related]
9. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis. Stricker H; Marchetti O; Haeberli A; Mombelli G Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903 [TBL] [Abstract][Full Text] [Related]
10. [Heparin treatment. Comparison between intravenous and subcutaneous administration]. Krähenbühl B; Simon CA; Bouvier CA; Schinas P; Hopf MA; Cochet B Schweiz Med Wochenschr; 1979 Sep; 109(36):1322-5. PubMed ID: 504973 [TBL] [Abstract][Full Text] [Related]
11. Use of an algorithm for administering subcutaneous heparin in the treatment of deep venous thrombosis. Prandoni P; Bagatella P; Bernardi E; Girolami B; Rossi L; Scarano L; Marchiori A; Piccioli A; Girolami A Ann Intern Med; 1998 Aug; 129(4):299-302. PubMed ID: 9729183 [TBL] [Abstract][Full Text] [Related]
12. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Elliott CG; Hiltunen SJ; Suchyta M; Hull RD; Raskob GE; Pineo GF; Jensen RL; Yeates S; Kitterman N Arch Intern Med; 1994 May; 154(9):999-1004. PubMed ID: 8179457 [TBL] [Abstract][Full Text] [Related]
13. The successful application of a heparin nomogram in a community hospital. Hollingsworth JA; Rowe BH; Brisebois FJ; Thompson PR; Fabris LM Arch Intern Med; 1995 Oct; 155(19):2095-100. PubMed ID: 7575069 [TBL] [Abstract][Full Text] [Related]
14. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium. Berkowitz SD Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421 [TBL] [Abstract][Full Text] [Related]
15. Heparin dosage adjustment in patients with deep-vein thrombosis using heparin concentrations rather than activated partial thromboplastin time. Groce JB; Gal P; Douglas JB; Steuterman MC Clin Pharm; 1987 Mar; 6(3):216-22. PubMed ID: 3665377 [TBL] [Abstract][Full Text] [Related]
16. [Subcutaneous injections and intravenous infusion of sodium salt of heparin in the treatment of thrombosis of deep veins of the lower extremities]. Lopaciuk S; Misiak A; Wisławski S; Ciesielski L; Korzycki J; Judkiewicz L; Lewandowski K; Tokarz A; Kłoczko J; Bielawiec M Pol Tyg Lek; 1990 Nov 19-26; 45(47-48):949-52. PubMed ID: 2104438 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population. Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443 [TBL] [Abstract][Full Text] [Related]
18. Intensive initial oral anticoagulation and shorter heparin treatment in deep vein thrombosis. Schulman S; Lockner D; Bergström K; Blombäck M Thromb Haemost; 1984 Dec; 52(3):276-80. PubMed ID: 6397871 [TBL] [Abstract][Full Text] [Related]
19. Continuous administration of heparin in patients with deep vein thrombosis can increase plasma levels of diamine oxidase. Klocker J; Perkmann R; Klein-Weigel P; Mörsdorf G; Drasche A; Klingler A; Fraedrich G; Schwelberger HG Vascul Pharmacol; 2004 Jan; 40(6):293-300. PubMed ID: 15063833 [TBL] [Abstract][Full Text] [Related]
20. [Continuous intravenous infusion versus intermittent administration of streptokinase in patients with deep venous thrombosis of the lower extremity]. Lopaciuk S; Meissner AJ; Ziemski JM; Tokarz A; Psuja P; Zawilska K; Głowiński S; Wołczyński Z; Czestochowska E; Tymiński W Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):704-7. PubMed ID: 1669137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]